Guardant Health, Inc.

NasdaqGS:GH 株式レポート

時価総額:US$3.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Guardant Health 将来の成長

Future 基準チェック /16

Guardant Health利益と収益がそれぞれ年間13.8%と16.5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に-38.9% 21%なると予測されています。

主要情報

13.8%

収益成長率

21.0%

EPS成長率

Healthcare 収益成長17.0%
収益成長率16.5%
将来の株主資本利益率-38.9%
アナリストカバレッジ

Good

最終更新日04 Jun 2024

今後の成長に関する最新情報

Recent updates

Guardant: Double-Digit Sales Projections Come At A Cost

Jun 06

Is Now The Time To Look At Buying Guardant Health, Inc. (NASDAQ:GH)?

Jun 04
Is Now The Time To Look At Buying Guardant Health, Inc. (NASDAQ:GH)?

Investors Appear Satisfied With Guardant Health, Inc.'s (NASDAQ:GH) Prospects As Shares Rocket 31%

May 14
Investors Appear Satisfied With Guardant Health, Inc.'s (NASDAQ:GH) Prospects As Shares Rocket 31%

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Mar 29
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For

Jan 21
With Guardant Health, Inc. (NASDAQ:GH) It Looks Like You'll Get What You Pay For

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Nov 20
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

Sep 26
Is There Now An Opportunity In Guardant Health, Inc. (NASDAQ:GH)?

A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)

Sep 05
A Look At The Fair Value Of Guardant Health, Inc. (NASDAQ:GH)

Is Guardant Health (NASDAQ:GH) A Risky Investment?

Aug 15
Is Guardant Health (NASDAQ:GH) A Risky Investment?

A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)

May 28
A Look At The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH)

Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Apr 05
Does Guardant Health (NASDAQ:GH) Have A Healthy Balance Sheet?

Is Guardant Health (NASDAQ:GH) Using Too Much Debt?

Dec 28
Is Guardant Health (NASDAQ:GH) Using Too Much Debt?

Guardant: Saving Lives One Blood Test At A Time

Oct 16

Here's Why Guardant Health (NASDAQ:GH) Can Afford Some Debt

Aug 15
Here's Why Guardant Health (NASDAQ:GH) Can Afford Some Debt

Guardant Health's test gets FDA win for companion diagnostic to Enhertu's expanded use in lung cancer

Aug 12

Guardant Health: Recent Developments Signal More Upsides

Jul 31

Guardant Health: Pending Recession, May Hurt Cancer Care Demand

Jul 14

業績と収益の成長予測

NasdaqGS:GH - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026985-319-230-15013
12/31/2025812-340-261-19120
12/31/2024681-386-295-23221
3/31/2024604-461-301-281N/A
12/31/2023564-479-345-325N/A
9/30/2023536-432-363-337N/A
6/30/2023510-508-383-337N/A
3/31/2023482-665-418-355N/A
12/31/2022450-655-387-309N/A
9/30/2022431-606-388-296N/A
6/30/2022408-551-363-271N/A
3/31/2022391-419-309-221N/A
12/31/2021374-406-284-209N/A
9/30/2021344-409-249-191N/A
6/30/2021324-379-191-146N/A
3/31/2021298-336-143-107N/A
12/31/2020287-254-158-104N/A
9/30/2020271-185-129-75N/A
6/30/2020258-120-118-66N/A
3/31/2020245-77-102-56N/A
12/31/2019214-76-68-47N/A
9/30/2019184-76-60-43N/A
6/30/2019145-87-81-67N/A
3/31/2019111-97-89-70N/A
12/31/201891-85-92-72N/A
9/30/201878-75-85-64N/A
6/30/201867-84-87-68N/A
3/31/201857-83-77-65N/A
12/31/201750-89N/A-72N/A
12/31/201625-46N/A-37N/A

アナリストによる今後の成長予測

収入対貯蓄率: GH今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: GH今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: GH今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: GHの収益 ( 16.5% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: GHの収益 ( 16.5% ) 20%よりも低い成長が予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: GH 3 年以内に赤字になると予測されています。


成長企業の発掘